ArticleCell death & disease2017

Disrupting CCT-β : β-tubulin selectively kills CCT-β overexpressed cancer cells through MAPKs activation.

Yan-Jin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.